Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting Conditions

NCT01182207 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Drospirenone/Ethinyl Estradiol (Gianvi®)
DRUG: YAZ®

Sponsor

Teva Pharmaceuticals USA